Terumo Medical Corporation has bought CaridianBCT for $2.63 billion, in the latest of a series of cross-border acquisitions by Japanese healthcare firms.
CaridianBCT started life as the blood-related division of a Swedish company called Gambro, which was bought in 2006 by Investor AB, a Nordic-based industrial-holding and private-equity firm. A year later, it restructured Gambro into three separate companies, one of which was Colorado-based CaridianBCT.
In the deal struck with Investor, Terumo has agreed to take on CaridianBCT with the debt on its books for an enterprise value of $2.63 billion, which translates to a multiple of 15 times trailing 2010...
¬ Haymarket Media Limited. All rights reserved.
